Defibrillator Sensor is a portable electronic device that automatically detects the life-threatening cardiac arrhythmias ventricular fibrillation and pulseless ventricular tachycardia, and is able to treat them through defibrillation, the application of electricity that stops the arrhythmia and enables the heart to reestablish a useful rhythm.
AEDs are made to be user-friendly for laypeople, with straightforward voice and visual directions, and the use of AEDs is covered in many first aid, certified first responder, and basic life support level cardiopulmonary resuscitation training. Both of these shockable cardiac arrhythmias have a defective electrical activity pattern that prevents the heart from pumping and circulating blood.
The heart beats too quickly in ventricular tachycardia to efficiently pump blood. Ventricular fibrillation is the end result of ventricular tachycardia. With ventricular fibrillation, the heart’s electrical system becomes disorganised, making it difficult for the ventricle to efficiently pump blood. During time, the heart’s fibrillation lessens and eventually reaches asystole.
AEDs are not intended to shock asystole because this will not have a beneficial therapeutic effect, like all defibrillators. The asystolic patient only has a chance of surviving if CPR and medications that stimulate the heart are used together. It is essential to perform CPR before a defibrillator arrives because it is possible to develop one of the shockable rhythms.
GLOBAL DEFIBRILLATOR SENSOR MARKET SIZE AND FORECAST
The Global Defibrillator Sensor market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
NEW PRODUCT LAUNCH
For medical professionals who respond to victims of sudden cardiac arrest, Philips Electronics launched the Philips HeartStart FR3 automated external defibrillator sensor. The HeartStart FR3 is the newest, smallest, and lightest professional-grade AED made by Philips.
The durable and dependable HeartStart FR3 is intended to assist professional responders save lives more quickly and easily. In order to utilise the FR3 in the United States, a prescription is required, and it must be used under a doctor’s supervision. One of the main reasons of death is SCA.
Ventricular fibrillation is the irregular heart rhythm most frequently linked to SCA, and defibrillation is acknowledged as the sole effective treatment. Cardiopulmonary resuscitation cannot by itself restore a normal heart rhythm, however it can assist extend the window of survival.
THIS REPORT WILL ANSWER FOLLOWING QUESTIONS
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.